International Review of Neurobiology
- 1st Edition, Volume 39 - February 2, 2012
- Latest edition
- Editors: Ronald J. Bradley, Robert Adron Harris, Peter Jenner
- Language: English
Since 1959, International Review of Neurobiology has been a well known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. This i… Read more
Since 1959, International Review of Neurobiology has been a well known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. This important serial is now being combined with Neuroscience Perspectives and Methods in Neurosciences. This combination results in a series that reaches a wider audience and publishes a greater number of thematic volumes.
- Modulation of inhibitory and excitatory neurotransmitter receptors by protein phosphorylation
- The use-dependent regulation of GABAA receptors
- Mechanisms of synaptic transmission in the neostriatum
- Regulation of neurotransmitters function by the neuronal cytoskeleton
- The anatomy and physiology of opioids in the hippocampus
- The molecular biology and pharmacology of the cannabinoid receptor
- The use of invertebrate and mammalian model systems in the study of the anesthetic drug action
- Ethanol effects on ion channels and locomotion
Researchers, clinicians, and graduate students in neuroscience, cell genetics, pharmacology, biology, and physiology
S.J. Moss and T.G. Smart, Modulation of Amino Acid-Gated Ion Channels by Protein Phosphorylation.
E.M. Barnes, Jr., Use Dependent Regulation of GABA<->A Receptors.
D.M. Lovinger and E. Tyler, Synaptic Transmission and Modulation in the Neostriatum.
V.J. Whatley and R.A. Harris, The Cytoskeleton and Neurotransmitter Receptors.
C. Chavkin, Endogenous Opinoid Regulation of Hippocampal Function.
M.E. Abood and B.R. Martin, Molecular Neurobiology of the Cannabinoid Receptor.
V.J. Simpson and T.E. Johnson, Genetic Models in the Study of Anesthetic Drug Action.
T.J. Phillips, Neurochemical Bases of Locomotion and Ethanols Locomotor Stimulant Effects.
F. Crews, L. Morrow, H. Criswell, and G. Breese, Ethanol Effects on Ion Channels.
Chapter References.
Subject Index.
Contents of Recent Volumes.
E.M. Barnes, Jr., Use Dependent Regulation of GABA<->A Receptors.
D.M. Lovinger and E. Tyler, Synaptic Transmission and Modulation in the Neostriatum.
V.J. Whatley and R.A. Harris, The Cytoskeleton and Neurotransmitter Receptors.
C. Chavkin, Endogenous Opinoid Regulation of Hippocampal Function.
M.E. Abood and B.R. Martin, Molecular Neurobiology of the Cannabinoid Receptor.
V.J. Simpson and T.E. Johnson, Genetic Models in the Study of Anesthetic Drug Action.
T.J. Phillips, Neurochemical Bases of Locomotion and Ethanols Locomotor Stimulant Effects.
F. Crews, L. Morrow, H. Criswell, and G. Breese, Ethanol Effects on Ion Channels.
Chapter References.
Subject Index.
Contents of Recent Volumes.
- Edition: 1
- Latest edition
- Volume: 39
- Published: February 2, 2012
- Language: English
RB
Ronald J. Bradley
Affiliations and expertise
Louisiana State University Medical Center, School of Medicine, Baton Rouge, U.S.A.RH
Robert Adron Harris
Affiliations and expertise
University of Texas, Austin, U.S.A.PJ
Peter Jenner
Professor Peter Jenner is a specialist in preclinical aspects of neurodegenerative diseases, notably Parkinson’s disease. He has spent the major part of his career at King’s College London where he was Head of Pharmacology for 14 years before returning to his research roots and subsequently becoming Emeritus Professor of Pharmacology. Peter has expertise in drug metabolism and pharmacokinetics but neuropharmacology based on functional models of neurodegenerative diseases has formed the major focus of his work. Peter holds a BPharm, PhD and DSc degree from the University of London. He has published well over 1000 articles with more than 700 peer reviewed papers. He is a Fellow of the Royal Pharmaceutical Society, the British Pharmacological Society, the Royal Society of Medicine and of King’s College London. Peter was recently honoured with a Doctor Honoris Causa degree from Carol Davila University of Medicine and Pharmacy, Bucharest and made an Honorary Fellow of The British Pharmacological Society for his contribution to research in to movement disorders.
Peter has worked closely with the pharmaceutical industry for many years and acts as an adviser and consultant to both major pharma and biotech companies. He has a wide knowledge of the drug discovery and drug development process and has been involved from molecule synthesis through to drug registration for use in man. Peter was the Founder, Director and Chief Scientific Officer of Proximagen, a biotech focussed on the treatment and cure of neurodegenerative diseases that was listed on AIMs and subsequently purchased by a US based healthcare company. He is a regular speaker at international meetings and also takes time to speak at Parkinson’s disease patient-carer groups across the UK.
Affiliations and expertise
Emeritus Professor of Pharmacology, Institute of Pharmaceutical Sciences, King’s College London, London, UKRead International Review of Neurobiology on ScienceDirect